FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $28,684,000 | +17.0% | 761,447 | -47.2% | 0.01% | 0.0% |
| Q4 2020 | $24,511,000 | +305.7% | 1,440,961 | +12.1% | 0.01% | +400.0% |
| Q3 2020 | $6,042,000 | -22.8% | 1,285,346 | +0.2% | 0.00% | -50.0% |
| Q2 2020 | $7,823,000 | +177.7% | 1,282,523 | +3.3% | 0.00% | +100.0% |
| Q1 2020 | $2,817,000 | -51.0% | 1,241,020 | -0.9% | 0.00% | 0.0% |
| Q4 2019 | $5,751,000 | -38.7% | 1,252,778 | -48.2% | 0.00% | -50.0% |
| Q3 2019 | $9,377,000 | -46.6% | 2,419,929 | -16.8% | 0.00% | -50.0% |
| Q2 2019 | $17,546,000 | -67.0% | 2,909,819 | -26.8% | 0.00% | -66.7% |
| Q1 2019 | $53,250,000 | +42.4% | 3,973,908 | -1.2% | 0.01% | +33.3% |
| Q4 2018 | $37,393,000 | -40.4% | 4,020,824 | -10.9% | 0.01% | -30.8% |
| Q3 2018 | $62,790,000 | -8.1% | 4,510,737 | +4.4% | 0.01% | -13.3% |
| Q2 2018 | $68,299,000 | -12.4% | 4,319,970 | -4.8% | 0.02% | -16.7% |
| Q1 2018 | $77,986,000 | +19.4% | 4,539,346 | +52.3% | 0.02% | +28.6% |
| Q4 2017 | $65,312,000 | -44.9% | 2,979,582 | +2.9% | 0.01% | -48.1% |
| Q3 2017 | $118,498,000 | +34.6% | 2,896,546 | -0.9% | 0.03% | +28.6% |
| Q2 2017 | $88,016,000 | +9.8% | 2,923,140 | +31.8% | 0.02% | +10.5% |
| Q1 2017 | $80,189,000 | -33.1% | 2,218,241 | -7.3% | 0.02% | -36.7% |
| Q4 2016 | $119,857,000 | -8.6% | 2,391,872 | -4.2% | 0.03% | -9.1% |
| Q3 2016 | $131,067,000 | +12.4% | 2,496,986 | -11.4% | 0.03% | +10.0% |
| Q2 2016 | $116,580,000 | -2.4% | 2,819,344 | -4.1% | 0.03% | -3.2% |
| Q1 2016 | $119,437,000 | -12.9% | 2,939,612 | -11.1% | 0.03% | -13.9% |
| Q4 2015 | $137,181,000 | +146.9% | 3,305,554 | -8.5% | 0.04% | +140.0% |
| Q3 2015 | $55,571,000 | -24.4% | 3,610,783 | +21.9% | 0.02% | -21.1% |
| Q2 2015 | $73,553,000 | -1.8% | 2,961,071 | -9.6% | 0.02% | 0.0% |
| Q1 2015 | $74,869,000 | +21.0% | 3,276,522 | +43.0% | 0.02% | +18.8% |
| Q4 2014 | $61,856,000 | +145.6% | 2,290,999 | +6.7% | 0.02% | +128.6% |
| Q3 2014 | $25,186,000 | -15.0% | 2,147,105 | +12.7% | 0.01% | -12.5% |
| Q2 2014 | $29,618,000 | -19.0% | 1,904,671 | +2.3% | 0.01% | -20.0% |
| Q1 2014 | $36,587,000 | +135.6% | 1,860,963 | +101.2% | 0.01% | +150.0% |
| Q4 2013 | $15,530,000 | – | 924,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,381,117 | $47,065,000 | 4.14% |
| GREAT POINT PARTNERS LLC | 1,647,753 | $22,937,000 | 3.58% |
| Rock Springs Capital Management LP | 598,000 | $8,324,000 | 0.30% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 136,029 | $1,894,000 | 0.14% |
| FOX RUN MANAGEMENT, L.L.C. | 20,935 | $291,000 | 0.13% |
| Hilltop Holdings Inc. | 39,824 | $554,000 | 0.12% |
| WEXFORD CAPITAL LP | 112,700 | $1,569,000 | 0.10% |
| OXFORD ASSET MANAGEMENT LLP | 296,339 | $4,132,000 | 0.09% |
| Vident Investment Advisory, LLC | 133,272 | $1,855,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 90,000 | $1,253,000 | 0.06% |